SA

Srinivas Arpula

Active Director Designated Partner DIN 09180546
DIN 09180546 First appointment May 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Srinivas Arpula

Data last updated:

Srinivas Arpula is a Designated Partner at Acquiant Pharma Chem Llp (since 2021). The company operates in Chemicals.

DIN 09180546
Primary Designation Designated Partner
Industry Chemicals
First Appointment 21 May 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 May 20212021Active

Board colleagues of Srinivas Arpula

NameDINCompanyDesignation
Narapa Reddy Vippala09085123Acquiant Pharma Chem LlpDesignated Partner
Vasudev Harianna Shetty09298981Acquiant Pharma Chem LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Acquiant Pharma Chem Llp
Premium access

Shareholding and investment profile for Srinivas Arpula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivas Arpula

Srinivas Arpula currently holds 1 directorship: Acquiant Pharma Chem Llp (Designated Partner, since 21 May 2021).

Srinivas Arpula was first appointed on 21 May 2021 as Designated Partner at Acquiant Pharma Chem Llp.

The current boards of Srinivas Arpula's companies include Narapa Reddy Vippala (Acquiant Pharma Chem Llp), Vasudev Harianna Shetty (Acquiant Pharma Chem Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available